- Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer
[作者:Charoenfuprasert, S; Yang, YY; Lee, YC; Chao, KC; Chu, PY; Lai, CR; Hsu, KF; Chang, KC; Chen, YC; Chen, LT; Chang, JY; Leu, SJ; Shih, NY,期刊:Oncogene, 页码:3570-3584 , 文章类型: Article,,卷期:2011年30-33]
- Existence of humoral immunity has been previously demonstrated in malignant ascitic fluids. However, only a limited number of immunogenic tumor-associated antigens (TAAs) were identified, and few of which are associated ...
- Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome
[作者:Pal, J; Bertheau, R; Buon, L; Qazi, A; Batchu, RB; Bandyopadhyay, S; Ali-Fehmi, R; Beer, DG; Weaver, DW; Reis, RJS; Goyal, RK; Huang, Q; Munshi, NC; Shammas, MA,期刊:Oncogene, 页码:3585-3598 , 文章类型: Article,,卷期:2011年30-33]
- A prominent feature of most cancers including Barrett's adenocarcinoma (BAC) is genetic instability, which is associated with development and progression of disease. In this study, we investigated the role of recombinase...
- Camptothecin-induced downregulation of MLL5 contributes to the activation of tumor suppressor p53
[作者:Cheng, F; Liu, J; Teh, C; Chong, SW; Korzh, V; Jiang, YJ; Deng, LW,期刊:Oncogene, 页码:3599-3611 , 文章类型: Article,,卷期:2011年30-33]
- Mixed lineage leukemia 5 (MLL5) has been implicated in multiple aspects of cell physiology, such as hematopoiesis, cell cycle control and chromatin regulatory network. In this study, we present evidence that MLL5 is invo...
- HGF-independent potentiation of EGFR action by c-Met
[作者:Dulak, AM; Gubish, CT; Stabile, LP; Henry, C; Siegfried, JM,期刊:Oncogene, 页码:3625-3635 , 文章类型: Article,,卷期:2011年30-33]
- The c-Met receptor is a potential therapeutic target for non-small cell lung cancer (NSCLC). Signaling interactions between c-Met and the mutant epidermal growth factor receptor (EGFR) have been studied extensively, but ...
- Bid can mediate a pro-apoptotic response to etoposide and ionizing radiation without cleavage in its unstructured loop and in the absence of p53
[作者:Maas, C; de Vries, E; Tait, SWG; Borst, J,期刊:Oncogene, 页码:3636-3647 , 文章类型: Article,,卷期:2011年30-33]
- BH3-only protein Bid is a key player in death receptor-induced apoptosis, because it provides the link with the mitochondrial route for caspase activation. In this pathway, Bid is activated upon cleavage by caspase-8. It...
- Suppression of cell-cycle progression by Jun dimerization protein-2 (JDP2) involves downregulation of cyclin-A2 (vol 29, pg 6245, 2010)
[作者:Pan, J; Nakade, K; Huang, YC; Zhu, ZW; Masuzaki, S; Hasegawa, H; Murata, T; Yoshiki, A; Yamaguchi, N; Lee, CH; Yang, WC; Tsai, EM; Obata, Y; Yokoyama, KK,期刊:Oncogene, 页码:3648-3648 , 文章类型: Correction,,卷期:2011年30-33]
-
- HEXIM1 is a critical determinant of the response to tamoxifen
[作者:Ketchart, W; Ogba, N; Kresak, A; Albert, JM; Pink, JJ; Montano, MM,期刊:Oncogene, 页码:3563-3569 , 文章类型: Article,,卷期:2011年30-33]
- Tamoxifen resistance is a major problem in the treatment of estrogen receptor (ER)-positive patients. We have previously reported that hexamethylene bis-acetamide-inducible protein 1 (HEXIM1) inhibits ER alpha activity b...
|